Navigation Links
Pexiganan Phase 3 Clinical Trials Results Published in December Issue of CID
Date:12/17/2008

Experts assess likelihood of use to treat mildly infected diabetic foot ulcers based upon data from randomized, controlled, double-blinded multi-center clinical trials of pexiganan cream

DALLAS, Dec. 17 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) and MACROCHEM CORPORATION (OTC Bulletin Board: MACM) announced today that the results of two Phase 3 studies of pexiganan for the topical treatment of mild diabetic foot infection were published in the December 15, 2008 issue of Clinical Infectious Diseases. The publication was authored by Benjamin A. Lipsky, M.D., Veteran's Affairs Puget Sound Healthcare System and the University of Washington School of Medicine, Seattle, WA; Kenneth J. Holroyd, M.D., Vanderbilt University School of Medicine, Nashville, TN; and Michael Zasloff, M.D., Georgetown University School of Medicine, Washington, D.C. The authors concluded that based on the data from these Phase 3 studies, topical pexiganan might be an effective alternative to oral antibiotic therapy in treating diabetic patients with a mildly infected foot ulcer, and might reduce the risk of selecting antimicrobial-resistant bacteria.

Overall, 835 patients were randomized; those in each treatment arm were similar with regard to dermographic and clinical characteristics. Although study 303 failed to demonstrate equivalence, study 304 and the combined data for the 2 trials demonstrated equivalent results (within the 95% confidence interval) for topical pexiganan and oral ofloxacin in clinical improvement rates (85%-90%), overall microbiological eradication rates (42%-47%), and wound healing rates. The incidence of worsening cellulitis (2%-4%) and amputation (2%-3%) did not differ significantly between treatment arms. Bacterial resistance to ofloxacin emerged in some patients who received ofloxacin, but no significant resistance to pexiganan emerged among patie
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Genaera Corporation Announces Licensing of Exclusive Rights to Pexiganan, a Novel Anti-Infective Drug Candidate, by Macrochem Corporation
2. CRSTI and Medical City Hospital Dallas Currently Recruiting For a Phase 2 Clinical Trial of MYDICAR(R) for Advanced Heart Failure
3. Wyeth Announces Positive Data from Phase 2 Study of Neratinib in Advanced HER-2-Positive Breast Cancer
4. Celator(R) Pharmaceuticals Presents Phase 1 Results With CPX-351 in Patients With Advanced Leukemia at the American Society of Hematology Meeting
5. Promising trials of malaria vaccine lead to calls for Phase 3 development
6. Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity
7. Phase 2 Results of Rigels R788 Show Clinical Benefit in Diffuse Large B-Cell Lymphoma and CLL
8. OnKua, Launches Phase I Of "Phyzoom" A Web-Based Physician Marketing And Customer Relationship Management Product
9. MannKind Reports Positive Results from Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes
10. Horizon Therapeutics announces 2 pivotal HZT-501 Phase 3 trials meet primary endpoints
11. SimQuest Awarded Phase 2 Contract from Office of the Secretary of Defense to Develop Pandemic Influenza Training Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... August 29, 2014 A recent article ... developed by a Tokyo clothing store for men with gynecomastia, ... of rectifying or diminishing their problem. Board-certified plastic surgeon Dr. ... the problem. While many people only associate male breasts with ... common condition among men of all ages, often starting in ...
(Date:8/29/2014)... Pursuing its deepest desires to help ... a stunning new design that promises to redefine the ... notable surrogacy platform has witnessed a 42 percent increase ... a month, the FindSurrogateMother.com community is formed by hopeful ... goal — the precious gift of life. , Whether ...
(Date:8/29/2014)... by the Mental Health Commission of Canada identifies ... education that police personnel receive. , "People with ... police community, and today,s report builds on the ... with mental illnesses," says Queen,s adjunct professor Dorothy ... the area of police psychology. "This is a ...
(Date:8/29/2014)... Washington, D.C. (PRWEB) August 29, 2014 ... Community Anti-Drug Coalitions of America (CADCA) , the ... statement in response to President Obama’s intent to nominate ... Policy: , “CADCA strongly supports President Obama’s decision to ... Botticelli is the ideal person to hold this important ...
(Date:8/29/2014)... Charlotte, NC (PRWEB) August 29, 2014 ... named to the prestigious Great 100 Nurses ... organization that recognizes nursing excellence and provides scholarships to ... The nurses recognized from Novant Health Presbyterian Medical ... Lynn Helderman, Lisa Kelley, Nora King, Lissa Ready, Amber ...
Breaking Medicine News(10 mins):Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 2Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 3Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 3Health News:Report advocates improved police training 2Health News:CADCA Statement on Nomination of Michael Botticelli as U.S. Drug Czar 2Health News:Great 100 Honors 13 Novant Health Nurses 2
... LOS ANGELES (June 24, 2010) The nerve cell-damaging ... disease also builds up in the retinas of the ... to the prospect that noninvasive optical imaging of the ... of the disease, according to new research. Scientists ...
... common mesenchymal tumors of the digestive tract. However, ... surgery is still the only curative approach for ... duodenal GIST. Some of these operations are extensive ... of the options is a more limited intervention: ...
... are proven to be more common in patients undergoing peritoneal ... However, whether the onset of these GI symptoms is related ... other factors, is still unknown. A research article ... World Journal of Gastroenterology addresses this question. The research ...
... levels of fungus may increase the risk of severe asthma ... a study from Harvard Medical School, Harvard Pilgrim Health Care ... was published online on the American Thoracic Society,s journal Web ... Journal of Respiratory and Critical Care Medicine . "We ...
... found that the drug carvedilol, currently prescribed for the ... Alzheimer,s disease and promote healthy memory functions. The new ... issues of Neurobiology of Aging and the ... are certainly very exciting, and suggest for the first ...
... 2010 -- The Accreditation Council for Graduate Medical ... training program standards today presented a comprehensive set ... and duty hours to better match residents, levels ... medical education and quality patient care in the ...
Cached Medicine News:Health News:Hallmark Alzheimer's disease changes found in retinas of humans and imaged in live animals 2Health News:Hallmark Alzheimer's disease changes found in retinas of humans and imaged in live animals 3Health News:What affects the gastrointestinal symptoms in peritoneal dialysis patients? 2Health News:Moldy homes a serious risk for severe asthma attacks in some 2Health News:Antihypertensive drugs may protect against Alzheimer's disease 2Health News:ACGME task force proposes graduated duty hour and supervision standards 2Health News:ACGME task force proposes graduated duty hour and supervision standards 3Health News:ACGME task force proposes graduated duty hour and supervision standards 4Health News:ACGME task force proposes graduated duty hour and supervision standards 5
(Date:8/29/2014)... , August 29, 2014 Pixcelldata, ... collaboration software has announced a major new deal with ... by renowned pathology expert, Dr. Marius Nap . ... the 26th European Congress of Pathology which is taking ... ExCeL Arena, London where Pixcelldata ...
(Date:8/28/2014)... Reportlinker.com announces that a new market research report ... America Aesthetic Lasers and Energy Devices Market Outlook ... North America Aesthetic Lasers and Energy ... GlobalData,s new report, "North America Aesthetic Lasers and ... market data on the North America Aesthetic Lasers ...
(Date:8/28/2014)... 2014 Reportlinker.com announces that a new ... Germany Aesthetic Lasers and Energy Devices ... http://www.reportlinker.com/p02343442/Germany-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html Germany Aesthetic Lasers and ... GlobalData,s new report, "Germany Aesthetic Lasers and ... market data on the Germany Aesthetic Lasers and ...
Breaking Medicine Technology:Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 2Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 3Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 4Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 5Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 6Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 7Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 8Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 9
... , , , , , , , ... 15 /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, Inc. ("China Sky ... fully integrated pharmaceutical company developing and producing,over-the-counter drugs in ... Company has relocated its headquarters to its new buildings,in the ...
... , GREENVILLE, S.C. , Jan. 14 ... online, real-time webcast and rebroadcast of its conference call on ... first quarter of fiscal 2010, which will be released after the ... broadcast of Span-America,s conference call will be available online at ...
Cached Medicine Technology:China Sky One Medical, Inc. Completes and Moves into New Corporate Headquarters 2China Sky One Medical, Inc. Completes and Moves into New Corporate Headquarters 3Span-America Announces First Quarter Conference Call On The Internet 2
... Series II Power Supplies. The EPS-2000-II, ... EPS-6000-II. These high-voltage power supplies offer ... power operating modes, with automatic crossover ... current/300 watts maximum power (except for ...
... power supply, 100-120 and 220-240 V, provides ... 1-500 W. The two-line, 16-character LCD allows ... of run progress. Built-in infrared capability allows ... a built-in switch when using either electrical ...
... PowerPac Basic power supply, 100-120 ... of 10-300 V, 4-400 mA, ... contains a built-in switch when ... the appropriate power cord. Power ...
... PRODUCT SPECIFICATIONS Form: Granular, free flowing powder EEO(-m r ... Point (3%): less than or equal to 31C ... 76C Gel Strength (3%): greater than or equal to ... or equal to 1000 gm/cm 2 Moisture: less ...
Medicine Products: